MediWound (MDWD) Net Margin (2014 - 2025)

MediWound's (MDWD) quarterly Net Margin came in at 413.87% in Q4 2025, down 30971.0% year-on-year from N/an in Q4 2024, and down 247.17% quarter-over-quarter from 119.21% in Q3 2025.

MediWound (MDWD) Net Margin (2014 - 2025) Analysis & Trends

MediWound's Net Margin history runs 12 years deep, the most recent figure standing at 413.87% for Q4 2025.

  • On a quarterly basis, Net Margin fell 30971.0% year-over-year to 413.87% in Q4 2025; TTM through Dec 2025 was 251.14%, a 12455.0% decrease from a year earlier, with the FY2025 full-year figure at 139.93%, up 919.0% from the prior year.
  • Net Margin retreated to 413.87% in Q4 2025 per MDWD's latest filing, from 119.21% in the prior quarter.
  • Across five years, Net Margin topped out at 77.94% in Q2 2023 and bottomed at 754.96% in Q2 2025.
  • The 5-year median for Net Margin is 104.16% (2024), against an average of 158.15%.
  • Across the five-year window, Net Margin jumped 33834 bps in 2023 and plunged 48289 bps in 2024, its largest moves.
  • Year by year, Net Margin stood at 75.82% in 2021, then advanced by 15 bps to 64.18% in 2022, then soared by 56 bps to 28.16% in 2023, then sank by 270 bps to 104.16% in 2024, then slumped by 297 bps to 413.87% in 2025.
  • Per Business Quant, the three latest MDWD Net Margin figures stand at 413.87% (Q4 2025), 119.21% (Q3 2025), and 754.96% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 MediWound 183.16 Mn 178.36 Mn 278,000.00 -413.87%

Historic Data

Download Data
DateValue
Dec 31, 2025 -413.87%
Sep 30, 2025 -119.21%
Jun 30, 2025 -754.96%
Mar 31, 2025 -131.98%
Dec 31, 2024 -104.16%
Sep 30, 2024 -116.19%
Jun 30, 2024 -404.94%
Mar 31, 2024 -74.74%
Dec 31, 2023 -28.16%
Sep 30, 2023 -43.97%
Jun 30, 2023 77.94%
Mar 31, 2023 -97.21%
Dec 31, 2022 -64.18%
Sep 30, 2022 -72.19%
Jun 30, 2022 -260.40%
Mar 31, 2022 -81.44%
Dec 31, 2021 -75.82%
Sep 30, 2021 -126.21%
Mar 31, 2021 -113.22%
Dec 31, 2020 -25.96%